Clinical Trial

Spinal Surgery Clinical Trial 20193175

[LCID Study Number: 20193175]

Prospective, Randomized, Controlled, Blinded Pivotal Study in Subjects Undergoing a Transforaminal Lumbar Interbody Fusion (TLIF) at One or Two Levels Using Infuse Bone Graft and the Capstone Spinal System with Posterior Supplemental Fixation for the Treatment of Symptomatic Degenerative Disease of the Lumbosacral Spine

The purpose of this study is to provide safety and effectiveness data of Infuse in Transforaminal Lumbar Interbody Fusion (TLIF) procedures and to obtain indication expansion for Infuse use in one and two level TLIF procedures.

Disease/Condition: Spinal Surgery

Department: Neurosurgery

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Clinical Trial Details

View NCT ID 04073563 on

Protocol #: 20193175

Principal Investigator(s): Zoher Ghogawala

Study Coordinator(s): Melissa Dunbar

Trial Phase: Sponsor Initiated Study Category B Device